Comparison of Sepsis Prediction Algorithms

NCT ID: NCT05943938

Last Updated: 2026-01-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

1200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2026-06-30

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Sepsis is a severe response to infection resulting in organ dysfunction and often leading to death. More than 1.5 million people get sepsis every year in the U.S., and 270,000 Americans die from sepsis annually. Delays in the diagnosis of sepsis lead to increased mortality. Several clinical decision support algorithms exist for the early identification of sepsis. The research team will compare the performance of three sepsis prediction algorithms to identify the algorithm that is most accurate and clinically actionable. The algorithms will run in the background of the electronic health record (EHR) and the predictions will not be revealed to patients or clinical staff. In this current evaluation study, the algorithms will not affect any part of a patient's care. The algorithms will be deployed across the Emory healthcare system on data from all patients presenting to the emergency department.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary goal of this study is to prospectively evaluate three sepsis prediction algorithms that are embedded in the EHR. The models will be deployed in a "shadow" mode, and the results will not be displayed to the treatment team during this study. Two of the algorithms are proprietary algorithms of the EHR provider (Epic). The third algorithm is an internally developed, open-source algorithm.

The algorithms will compute the probability of sepsis at periodic intervals and will continue to run on a patient's data until the patient's discharge, death, or upon initiation of intravenous antibiotics (at which point there is an indirect record of clinical suspicion of an infection).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sepsis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ED Patients

All adult patients presenting to Emergency Departments (ED) in the Emory Healthcare system

Epic Sepsis Model Version - 1

Intervention Type OTHER

The Epic Sepsis Model (ESM) version 1, a proprietary sepsis prediction model.

Epic Sepsis Model Version - 2

Intervention Type OTHER

The Epic Sepsis Model (ESM) version 2, a proprietary sepsis prediction model.

Emory Sepsis Model

Intervention Type OTHER

Emory internal algorithm

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Epic Sepsis Model Version - 1

The Epic Sepsis Model (ESM) version 1, a proprietary sepsis prediction model.

Intervention Type OTHER

Epic Sepsis Model Version - 2

The Epic Sepsis Model (ESM) version 2, a proprietary sepsis prediction model.

Intervention Type OTHER

Emory Sepsis Model

Emory internal algorithm

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Proprietary Epic sepsis algorithm -1 Proprietary Epic sepsis algorithm -2 Emory Sepsis Algorithm

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All adult patients admitted through the ED

Exclusion Criteria

* None
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Emory University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Siva Bhavani

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sivasubramanium Bhavani, MD

Role: PRINCIPAL_INVESTIGATOR

Emory University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Emory Midtown Hospital

Atlanta, Georgia, United States

Site Status

Emory Saint Joseph's Hospital

Atlanta, Georgia, United States

Site Status

Emory Healthcare System

Atlanta, Georgia, United States

Site Status

Emory Hospital

Atlanta, Georgia, United States

Site Status

Emory Decatur Hospital

Decatur, Georgia, United States

Site Status

Emory Johns Creek Hospital

Johns Creek, Georgia, United States

Site Status

Emory Hillandale Hospital

Lithonia, Georgia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sivasubramanium Bhavani, MD

Role: CONTACT

404-712-2970

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sivasubramanium Bhavani, MD

Role: primary

(404) 501-1000

Sivasubramanium Bhavani, MD

Role: primary

404-712-2970

Sivasubramanium Bhavani, MD

Role: primary

(404) 501-8000

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024P008316

Identifier Type: OTHER

Identifier Source: secondary_id

STUDY00005958

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Early Prediction of Sepsis
NCT04570618 COMPLETED NA
RCT of Sepsis Machine Learning Algorithm
NCT03882476 WITHDRAWN PHASE2
Molecular Biomarkers for Sepsis
NCT04280354 TERMINATED